187 related articles for article (PubMed ID: 31280616)
1. Treatment of newly-diagnosed gastroesophageal reflux disease: a nationwide register-based cohort study.
Ljungdalh JS; Rubin KH; Durup J; Houlind KC
Scand J Gastroenterol; 2019 Jul; 54(7):830-837. PubMed ID: 31280616
[No Abstract] [Full Text] [Related]
2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis.
Familiari P; Greco S; Gigante G; Calì A; Boškoski I; Onder G; Perri V; Costamagna G
Dig Endosc; 2016 Jan; 28(1):33-41. PubMed ID: 26173511
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
[TBL] [Abstract][Full Text] [Related]
9. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
Williams JF; Sontag SJ; Schnell T; Leya J
Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease (GERD) in children.
Poddar U
Paediatr Int Child Health; 2019 Feb; 39(1):7-12. PubMed ID: 30080479
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC).
Zou D; He J; Ma X; Chen J; Gong Y; Man X; Gao L; Wang R; Zhao Y; Yan X; Liu W; Wernersson B; Johansson S; Dent J; Sung JJ; Li Z
Scand J Gastroenterol; 2011 Feb; 46(2):133-41. PubMed ID: 20955088
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal Reflux Disease-Related Disorders of Systemic Sclerosis Based on the Analysis of 66 Patients.
Matsuda R; Yamamichi N; Shimamoto T; Sumida H; Takahashi Y; Minatsuki C; Kodashima S; Ono S; Niimi K; Tsuji Y; Sakaguchi Y; Saito I; Kataoka Y; Asada-Hirayama I; Kakimoto H; Yakabi S; Takeuchi C; Matsumoto Y; Tamaki Z; Fujishiro M; Asano Y; Sato S; Koike K
Digestion; 2018; 98(4):201-208. PubMed ID: 30045036
[TBL] [Abstract][Full Text] [Related]
13. [Gastroesophageal reflux in the French general population: national survey of 8000 adults].
Bretagne JF; Richard-Molard B; Honnorat C; Caekaert A; Barthélemy P
Presse Med; 2006 Jan; 35(1 Pt 1):23-31. PubMed ID: 16462660
[TBL] [Abstract][Full Text] [Related]
14. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.
Bhatia SJ; Makharia GK; Abraham P; Bhat N; Kumar A; Reddy DN; Ghoshal UC; Ahuja V; Rao GV; Devadas K; Dutta AK; Jain A; Kedia S; Dama R; Kalapala R; Alvares JF; Dadhich S; Dixit VK; Goenka MK; Goswami BD; Issar SK; Leelakrishnan V; Mallath MK; Mathew P; Mathew P; Nandwani S; Pai CG; Peter L; Prasad AVS; Singh D; Sodhi JS; Sud R; Venkataraman J; Midha V; Bapaye A; Dutta U; Jain AK; Kochhar R; Puri AS; Singh SP; Shimpi L; Sood A; Wadhwa RT
Indian J Gastroenterol; 2019 Oct; 38(5):411-440. PubMed ID: 31802441
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
16. Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study.
Jansson C; Wiberg M; Alexanderson K
Scand J Gastroenterol; 2013 Jan; 48(1):17-26. PubMed ID: 23181538
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study.
Kim KM; Cho YK; Bae SJ; Kim DS; Shim KN; Kim JH; Jung SW; Kim N
J Gastroenterol Hepatol; 2012 Apr; 27(4):741-5. PubMed ID: 21916988
[TBL] [Abstract][Full Text] [Related]
18. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
19. Refractory gastroesophageal reflux disease.
Moraes-Filho JP
Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
[TBL] [Abstract][Full Text] [Related]
20. Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy.
Shaheen NJ; Denison H; Björck K; Silberg DG
Am J Gastroenterol; 2013 Apr; 108(4):529-34. PubMed ID: 23318482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
